S.I. No. 625/2025 - Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 4) Regulations 2025

Notice of the making of this Statutory Instrument was published in

“Iris Oifigiúil” of 30th December, 2025.

I, JENNIFER CARROLL MACNEILL, Minister for Health, in exercise of the powers conferred on me by section 32 (as amended by section 9 of the Health (Miscellaneous Provisions) Act 2024 (No. 23 of 2024)) of the Irish Medicines Board Act 1995 (No. 29 of 1995), hereby make the following regulations:

1. These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 4) Regulations 2025.

2. The collective citation “the Medicinal Products (Prescription and Control of Supply) Regulations 2003 to 2025” includes these regulations.

3. In these Regulations “Principal Regulations” means the Medicinal Products (Prescription and Control of Supply) Regulations 2003 ( S.I. No. 540 of 2003 ).

4. The Thirteenth Schedule (as inserted by Regulation 8 of the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 3) Regulations 2025 ( S.I. No. 502 of 2025 )) to the Principal Regulations is amended by inserting after the entry for “Trimethoprim” the following entry:

“

”.

GIVEN under my Official Seal,

17 December, 2025.

JENNIFER CARROLL MACNEILL,

Minister for Health.

EXPLANATORY NOTE

(This note is not part of the Instrument and does not purport to be a legal interpretation.)

These Regulations amend the Medicinal Products (Prescription and Control of Supply) Regulations 2003.

The purpose of these Regulations is to update the schedule of medicinal products which may be prescribed by registered pharmacists pursuant to Regulation 5C of the Medicinal Products (Prescription and Control of Supply) Regulations 2003.

These Regulations may be cited as the Medicinal Products (Prescription and Control of Supply) (Amendment) (No. 4) Regulations 2025.